Blood transfusion utilization and recipient survival at Hospital das Clinicas in Sao Paulo, Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
GONCALEZ, Thelma T.
LIU, Jing
WRIGHT, David J.
WALSH, Judy H.
FERREIRA, Joao E.
BUSCH, Michael P.
CUSTER, Brian
Citação
TRANSFUSION, v.52, n.4, p.729-738, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND: The characteristics of blood recipients including diagnoses associated with transfusion and posttransfusion survival are unreported in Brazil. The goals of this analysis were: 1) to describe blood utilization according to clinical diagnoses and patient characteristics and 2) to determine the factors associated with survival of blood recipients. STUDY DESIGN AND METHODS: A retrospective cross-sectional analysis was conducted on all inpatients in 2004. Data came from three sources: The first two files consist of data about patient characteristics, clinical diagnosis, and transfusion. Analyses comparing transfused and nontransfused patients were conducted. The third file was used to determine survival recipients up to 3 years after transfusion. Logistic regression was conducted among transfused patients to examine characteristics associated with survival. RESULTS: In 2004, a total of 30,779 patients were admitted, with 3835 (12.4%) transfused. These patients had 10,479 transfusions episodes, consisting of 39,561 transfused components: 16,748 (42%) red blood cells, 15,828 (40%) platelets (PLTs), and 6190 (16%) plasma. The median number of components transfused was three (range, 1-656) per patient admission. Mortality during hospitalization was different for patients whose admissions included transfusion or not (24% vs. 4%). After 1 year, 56% of transfusion recipients were alive. The multivariable model of factors associated with mortality after transfusion showed that the most significant factors in descending order were hospital ward, increasing age, increasing number of components transfused, and type of components received. CONCLUSION: Ward and transfusion are markers of underlying medical conditions and are associated with the probability of survival. PLT transfusions are common and likely reflect the types of patients treated. This comprehensive blood utilization study, the first of its kind in Brazil, can help in developing transfusion policy analyses in South America.
Palavras-chave
Referências
  1. Ali A, 2010, TRANSFUSION, V50, P584, DOI 10.1111/j.1537-2995.2009.02490.x
  2. [ANVISA BNHVA-ANdV], 2003, MAN HEM, V3, P1
  3. ANVISA ANDVS, 2009, ANVISA ANDVS B HEM, V2, P13
  4. Beguin C, 1998, Acta Anaesthesiol Belg, V49, P141
  5. Boin IFSF, 2008, TRANSPL P, V40, P789, DOI 10.1016/j.transproceed.2008.02.058
  6. BORKENTRAVEN BA, 2010, TRANSFUSION, V100, P196
  7. Bosch MA, 2010, TRANSFUSION, V51, P105
  8. Capuani L, 2010, VOX SANG S1, V99, P18
  9. Chiavetta JA, 1996, TRANSFUSION, V36, P699, DOI 10.1046/j.1537-2995.1996.36896374373.x
  10. Cobain TJ, 2007, TRANSFUSION MED, V17, P1, DOI 10.1111/j.1365-3148.2006.00709.x
  11. dos Santos AM, 2009, TRANSFUSION, V50, P150
  12. Fraga GP, 2009, J EMERGENCY MED, V39, P253
  13. Garcia-Erce JA, 2010, BLOOD TRANSFUS-ITALY, V8, P100, DOI 10.2450/2009.0079-09
  14. Gawryszewski Vilma Pinheiro, 2004, Cad Saude Publica, V20, P995
  15. Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446
  16. Hajjar Ludhmila Abrahao, 2007, Clinics (Sao Paulo), V62, P507
  17. IBGE, DAD SAO PAUL DAD CEN
  18. IBGE, 2005, 2004 BRAZ LIF EXP RE
  19. IBGE, 2011, CENS 2010
  20. Kamper-Jorgensen M, 2008, TRANSFUSION, V48, P2577, DOI 10.1111/j.1537-2995.2008.01881.x
  21. Kamper-Jorgensen M, 2009, TRANSFUSION, V49, P888, DOI 10.1111/j.1537-2995.2008.02081.x
  22. Kleinman S, 2004, TRANSFUSION, V44, P386, DOI 10.1111/j.1537-2995.2003.00660.x
  23. Lim YA, 2004, VOX SANG, V86, P54, DOI 10.1111/j.0042-9007.2004.00385.x
  24. Madsen JT, 2010, TRANSFUSION MED, V20, P191, DOI 10.1111/j.1365-3148.2009.00977.x
  25. Mathoulin-Pelissier S, 1997, TRANSFUS CLIN BIOL, V4, P533, DOI 10.1016/S1246-7820(97)80078-X
  26. Modelli MES, 2008, REV SAUDE PUBL, V42, P350, DOI 10.1590/S0034-89102008005000012
  27. Quaranta JF, 2009, TRANSFUS CLIN BIOL, V16, P21, DOI 10.1016/j.tracli.2009.02.002
  28. Shan H, 2002, LANCET, V360, P1770, DOI 10.1016/S0140-6736(02)11669-2
  29. Sullivan MT, 2007, TRANSFUSION, V47, P385, DOI 10.1111/j.1537-2995.2007.01128.x
  30. Syrjala MT, 2001, TRANSFUSION MED, V11, P423, DOI 10.1046/j.1365-3148.2001.00338.x
  31. Titlestad K, 2001, VOX SANG, V80, P40, DOI 10.1046/j.1423-0410.2001.00001.x
  32. Wallis JP, 2004, TRANSFUSION, V44, P1025, DOI 10.1111/j.1537-2995.2004.03400.x
  33. Wells AW, 2009, TRANSFUSION MED, V19, P315, DOI 10.1111/j.1365-3148.2009.00933.x
  34. Wells AW, 2002, BRIT MED J, V325, P803, DOI 10.1136/bmj.325.7368.803
  35. WHO, 2008, UN ACC SAF BLOOD
  36. World Health Organisation, 2007, INT CLASS DIS ICD
  37. Zimmermann R, 1997, TRANSFUSION, V37, P1075, DOI 10.1046/j.1537-2995.1997.371098016449.x